RVP stock forecast
Our latest prediction for Retractable Technologies Inc's stock price was made on the Jan. 4, 2023 when the stock price was at 1.84$.
In the short term (2weeks), RVP's stock price should underperform the market by -1.88%. During that period the price should oscillate between -10.29% and +7.56%.
In the medium term (3months), RVP's stock price should underperform the market by -2.63%. During that period the price should oscillate between -27.98% and +23.34%.
Get email alertsCreate a solid portfolio with RVP
About Retractable Technologies Inc
Retractable manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe® syringes are uniquely designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint® is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint® needle also can be used to aspirate fluids and for blood collection. Retractable's products are distributed by various specialty and general line distributors.
At the moment the company generates 145M USD in revenues.
On its last earning announcement, the company reported a profit of 0.89$ per share.
The book value per share is 0.77$
Three months stock forecastJan. 4, 2023
Financials
| Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 145M | 39.92% | 35M | 24.33% | 30M | 0.89 | - | - | 32M | 0.77 | - | - | - |